- Stocks
- Pharma & Healthcare
- Achyut Health
Achyut Health share price
NSE: ACHYUTPharma & HealthcarePharmaceutical Retailers
Achyut Health at a glance
With a market capitalisation of ₹209 Cr, it ranks 2253rd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Pharmaceutical Retailers.
At its last close the stock traded at 100× trailing earnings, against a return on equity of 1.7% in FY25. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹4 Cr (+377.2% year on year) and net profit ₹0 Cr (−50.0%), on a standalone basis. Promoters held 47.32% of the company as of 30 Jun 2026.
Key numbers
- Market cap
- ₹209 CrRank 2253 on NSE
- P/E (trailing)
- 100×
- Price to book
- 2.45×FY25
- EPS (TTM)
- ₹0.01to Q4 FY26
- ROE
- 1.7%FY25
- ROCE
- 2.2%FY25
- Debt to equity
- 0FY25
- Net profit margin
- 18.0%FY25
- Book value / share
- ₹1.33FY25
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | — | — | — | — | — |
Achyut Health quarterly results
| Quarter | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|
| Revenue | — | ₹1 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹4 Cr |
| Revenue YoY | — | — | — | — | — | +377.2% |
| Net profit | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Net profit YoY | — | — | — | — | −100.0% | −50.0% |
| Net margin | — | 13.0% | 3.6% | 4.7% | 0.0% | 1.4% |
| EPS | ₹0.00 | ₹0.01 | ₹0.00 | ₹0.01 | ₹0.00 | ₹0.00 |
Achyut Health financials
| Item | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Revenue | ₹4 Cr | ₹3 Cr | ₹6 Cr | ₹3 Cr |
| Operating profit | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr |
| Net profit | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr |
| EPS (₹) | ₹0.15 | ₹0.31 | ₹0.34 | ₹0.02 |
| Cash from operations | −₹7 Cr | −₹0 Cr | −₹0 Cr | −₹4 Cr |
| Total debt | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Shareholders' equity | ₹9 Cr | ₹15 Cr | ₹31 Cr | ₹31 Cr |
Achyut Health shareholding pattern
| Holder | 30 Sep 2025 | 23 Mar 2026 | 24 Mar 2026 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|
| Promoters | 47.07% | 47.40% | 47.40% | 47.40% | 47.32% |
| Foreign institutions | 5.26% | 5.13% | 5.13% | 5.13% | 5.13% |
| Non-institutions | 47.67% | 47.48% | 47.48% | 47.48% | 47.55% |
Achyut Health vs peers
The listed Pharma & Healthcare companies nearest to Achyut Health by market capitalisation.
| Company | Price | 1 day | 1 year | Market cap | P/E | ROE |
|---|---|---|---|---|---|---|
| NECLIFENectar Lifesciences | ₹11.34 | −0.09% | −16.5% | ₹220 Cr | 100 | −50.3% |
| HANNAHHannah Joseph | — | — | — | ₹220 Cr | — | 13.9% |
| SYSCHEMSyschem (India) | — | — | — | ₹214 Cr | — | — |
| ACHYUTAchyut Health | — | — | — | ₹209 Cr | 100 | 1.7% |
| CORALABCoral Labs | — | — | — | ₹196 Cr | 10 | 12.0% |
| AASHKAAashka Hospital | — | — | — | ₹190 Cr | 50 | 3.2% |
| BROOKSBrooks Laboratories | ₹63.12 | +4.31% | −49.8% | ₹186 Cr | 7.6 | −10.2% |
Ask anything about Achyut Health
Pivot answers on the live chart with evidence you can check, and tests strategies against ACHYUT's own history. Try: “Why has ACHYUT moved over the last three months?” · “Backtest a 50-day moving-average crossover on ACHYUT over five years” · “Compare ACHYUT with NECLIFE on margins and valuation”
Frequently asked questions about Achyut Health
What is the market cap of Achyut Health?
Achyut Health's market capitalisation is ₹209 Cr (₹209 Cr) at the 22 Oct 2026 close, ranking 2253rd among the NSE companies Pivot tracks.
What is the P/E ratio of Achyut Health?
Achyut Health trades at a trailing P/E of 100. The median P/E of the 4 closest Pharma & Healthcare peers by market cap is 50.
What is the ROE and ROCE of Achyut Health?
Return on equity was 1.7% in FY25 and return on capital employed was 2.2% in FY25 (standalone figures).
Is Achyut Health a debt-free company?
Achyut Health is close to debt-free: its debt-to-equity ratio was 0 in FY25.
What were Achyut Health's latest quarterly results?
For Q4 FY26 (quarter ended 31 Mar 2026), Achyut Health reported revenue of ₹4 Cr, +377.2% year on year, and net profit of ₹0 Cr, −50.0% year on year.
What is the shareholding pattern of Achyut Health?
As of 30 Jun 2026: promoters 47.32%, foreign institutions 5.13%, non-institutions 47.55%.
Who are Achyut Health's competitors?
The listed Pharma & Healthcare companies closest to Achyut Health by market cap are Nectar Lifesciences, Hannah Joseph, Syschem (India), Coral Labs, Aashka Hospital and Brooks Laboratories.
Is Achyut Health a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Achyut Health's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on ACHYUT against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, standalone where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Pharma & Healthcare stocks · companies starting with A · all NSE stocks · this page as text